Feasibility and Suitability of Targeting Young Gay Men for HIV Vaccine Efficacy Trials
- 1 February 1999
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 20 (2) , 172-178
- https://doi.org/10.1097/00042560-199902010-00010
Abstract
We evaluated factors affecting the feasibility of including young high-risk HIV-negative gay and bisexual men in preventive HIV vaccine trials using data from the U.S. Centers for Disease Control and Prevention Collaborative HIV Seroincidence Study. Of 2189 men enrolled in this study, 17% were HIVKeywords
This publication has 10 references indexed in Scilit:
- Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United StatesAIDS, 1998
- Feasibility of Human Immunodeficiency Virus Vaccine Trials in Homosexual Men in the United States: Risk Behavior, Seroincidence, and Willingness to ParticipateThe Journal of Infectious Diseases, 1996
- The feasibility of HIV-1 vaccine efficacy trials among gay/bisexual men in New York City: Project ACHIEVEAIDS, 1996
- Will Preventive HIV Vaccine Efficacy Trials Be Possible With Female Injection Drug Users?JAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
- HIV infection in homosexual and bisexual men 18 to 29 years of age: the San Francisco Young Men's Health Study.American Journal of Public Health, 1994
- Seroprevalence of HIV and risk behaviors among young homosexual and bisexual men. The San Francisco/Berkeley Young Men's SurveyPublished by American Medical Association (AMA) ,1994
- Epidemiological and public health considerations in the design of HIV vaccine trialsAIDS, 1991
- AIDS risk and prevention among adolescentsSocial Science & Medicine, 1991
- High HIV risk-taking among young gay menAIDS, 1990
- Maintenance of safer sexual behaviors and predictors of risky sex: the San Francisco Men's Health Study.American Journal of Public Health, 1990